IHS Clinical Webinar Series 2025: Update on Gene Therapy and Gene Editing in Haemophilia
Featuring Professor David Lillicrap, Professor in the Department of Pathology and Molecular Medicine at Queen’s University in Kingston, Ontario.
Featuring Professor David Lillicrap, Professor in the Department of Pathology and Molecular Medicine at Queen’s University in Kingston, Ontario.
Featuring Dr. Peter Lenting, National Institute for Health and Medical Research, Paris.
The American Society of Hematology (ASH) Annual Meeting is the world's largest and most comprehensive haematology event of the year. With hundreds of sessions showcasing the latest research and practice…
Featuring Dr. Glenn Pierce, Vice President Medical of the World Federation of Hemophilia (WFH), USA
The recent withdrawal of Roctavian from the market has raised important questions for clinicians, patients, and healthcare systems involved in the management of haemophilia A gene therapy. As the first…
The WFH 2026 World Congress will include over 80 hours of continuing educational sessions across the Medical and People with Bleeding Disorders (PWBD) tracks, as well as six professional development…
The European Hematology Association (EHA) community consists of doctors (haematologists), researchers (PhD or otherwise), patients (and advocacy groups), geneticists, nurses, and more mainly across Europe, including non-EU member states.
Gene therapy is transforming the treatment landscape of hemophilia, but major questions remain regarding its use in patients with current or past inhibitors. In this webinar, leading experts will discuss…